PALI

Conviction 42HealthcareScan · Thu, Sep 24, 2026

Hammer

Palisade Bio, Inc. (PALI) closed at $1.58 (-1.25%) on Sep 24, 2026. Its latest daily candle is a hammer. Price is below its 50-day and below its 200-day moving average. RSI(14) 33, RS Rating 98, -43.6% from its 52-week high, -36.8% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

PALI$1.58-1.25%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 4.15M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

PALISADE BIO, INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.palisadebio.com ↗

Price1.58

Change-1.25%

Gap-1.56%

Rel volume2.16×

Avg volume3.27M

Avg $ vol5.93M

SMA 201.90

SMA 501.98

SMA 2001.93

Price vs 50-20.23%

Price vs 200-18.22%

MA stackmixed

50/200 cross—

Supertrenddown · 1.91

RSI (14)33

MACD hist-0.04

MACD cross—

Stoch %K / %D11 / 10

ADX (14)24

+DI / −DI11 / 32

RSI divergence—

MACD divergence—

ATR %7.71%

ADR %6.16%

52w high2.80

52w low0.6844

From 52w high-43.57%

Above 52w low+130.86%

New 52w highNo

SqueezeOff

Bollinger width41.28%

%B0.09

Donchian pos10.88%

Donchian high2.24

Donchian low1.50

AVWAP (52w high)1.96

vs AVWAP high-19.40%

AVWAP (52w low)1.85

vs AVWAP low-14.64%

OBV trendDown

Chaikin MF (20)-0.12

Today vs 20d2.16×

Avg vol (14d)4.15M

Avg vol (20d)3.27M

Avg $ vol (20d)5.93M

Market cap275.35M

RS Rating98 / 99

RS 3m (vs SPY)-16.71%

RS 6m (vs SPY)-37.82%

RS line new highNo

Trend template3/8

Technical rank13.5

1 week-7.06%

1 month-23.67%

3 months-12.22%

6 months-21.00%

1 year+149.84%

YTD-36.80%

P/E-16.41

P/B2.26

P/S—

P/FCF-25.38

EPS-0.3000

Div yield—

ROE-13.78%

ROA-13.18%

Debt/Eq0.00

Current24.26

EV/EBITDA-8.32

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth-16.23%

Price target10.00

Target upside532.91%

Analyst ratingBuy

Institutional106.81%

Ent. value150.26M

Revenue500K

Net income-10.57M

Gross profit—

Free cash flow-10.85M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out173.58M

Employees14

ListedWed, Apr 28, 2021

Free float164.96M

Float %99.4%

Short interest30.9M

Days to cover19.1d

Short volume62.8%

Squeeze score93 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.05 vs −$0.05

Last surprise0.0% beat

Setup gradeD

Conviction42 / 100

Pattern quality—

Tech rank13.5 / 100

Group rank59 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmHammer

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Breaking out now
Sep 8
1 scan
→
Setting up
Sep 9
1 scan

Congress activity

Disclosed STOCK Act trades in PALI

All disclosures →

No recent disclosed trades by Congress in PALI. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PALI · open-market 3 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Finley John David CEO, CFO · Common Stock · 2026-08-19	Gift	88.4K	—	2026-08-19	2026-08-21
Finley John David CEO, CFO · Common Stock · 2026-08-19	Gift	88.4K	—	2026-08-19	2026-08-21
Baltera Robert Jr. Director · Common Stock · 2026-07-09	Buy	25K	$49K	2026-07-09	2026-07-10
Baltera Robert Jr. Director · Common Stock · 2026-07-08	Buy	20K	$40K	2026-07-08	2026-07-10
Finley John David CEO, CFO · Common Stock · 2026-07-07	Exercise	133	$93	2026-07-07	2026-07-08
Finley John David CEO, CFO · Common Stock · 2026-07-07	Sell	146.8K	$303K	2026-07-07	2026-07-08
Finley John David CEO, CFO · Series 2 Common Stock Purchase Warrant · 2026-07-07	Exercise	133	—	2026-07-07	2026-07-08
Jones Mitchell Lawrence Chief Medical Officer · Common Stock · 2026-07-07	Sell	51.88K	$107K	2026-07-07	2026-07-08
Baltera Robert Jr. Director · Common Stock · 2026-07-07	Buy	30K	$61K	2026-07-07	2026-07-08
Finley John David CEO, CFO · Common Stock · 2026-07-06	Exercise	335.17K	—	2026-07-06	2026-07-08

SEC filings

EDGAR filings in PALI · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.